Hyaluronic Acid Based Dermal Fillers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Hyaluronic Acid Based Dermal Fillers Market
The hyaluronic acid based dermal fillers market size was valued at USD 3.88 billion in 2022, and the market is now projected to grow from USD 4.13 billion in 2023 to USD 7.15 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period of 2023-2030.
The marketplace of hyaluronic acid-primarily based dermal fillers became now not useful within the year 2020 because the COVID-19 virus outbreak severely impacted the marketplace. This is why non-invasive surgeries were ceased, and the admission rate of anti-aging treatment was never high during the period of pandemic. This COVID-19 virus affects various categories of industries, and because of the virus outbreak, there were challenges in producing raw HA. The possibly affected areas' closure by the government in a bid to contain the virus spread unwillingly impacted the chain of hyaluronic acid and thus exerted a negative impact on the hyaluronic acid based dermal fillers market growth.
HA has recently become an important tool in all treatments that are related to cosmetics, especially because it makes the skin moisturized and filled which is employed during anti-aging treatments that do not require surgery. This is because the societal desire towards an aesthetically preferable youthful look persists and people will do all that is possible to achieve smooth skin which has led to the development of HA fillers as a minimally invasive procedure in the dermatology system and is expected to elevate the system and grow the market. Similarly, the availability of extensive numbers of hospitals and specialized dermatological centres offering various cosmetic treatments inclusive to dermal fillers formulated with HA all over the world has been assumed to propel the market. There are also many new products that have been approved which in one way or another has altered the entire mode of the industry and the approved list of products is still expanding. Each of the aforementioned factors has an impact on the hyaluronic acid based dermal fillers market share.
Producers who are new to the market have observed this incidence of the youthful folks getting the filler procedures carried out and have provided you with their merchandise which can be made from HA-based fillers. Some of the elements which include improving human beings’s perception of beauty among the people, and the advent of particular stylish merchandise and items in particular for teenagers due to the seasonal trade inside the fashion industry are expected to push the overall marketplace forward in the future years.
Comprehensive Analysis of Hyaluronic Acid Based Dermal Fillers Market
The well-rounded market study of hyaluronic acid-based dermal fillers entails the market classification by crosslinking type, application, and end client. According to the type of crosslinking, it includes the monophasic and biphasic fillers which are used according to texture or hardness. Applicators of the market also include scar treatment, wrinkle correction treatment, lip enhancement, and restoration of volume fullness and some of the key end users of the market are specialty and dermatology clinics hospitals clinics, or other healthcare provider organizations.
The centered market of North America is worth USD 1. 64 billion in 2022 and is anticipated to grow at an awesome tempo for the duration of the span of the identical duration. The compound increase is because monophasic offerings are quickly getting followed, having a nicely-evolved healthcare gadget, and substantial research and development sports by way of key players.
Allergan Aesthetics (AbbVie ) (U.S.), Revance Therapeutics, Inc. (U.S.), Merz Pharma (Germany), Galderma (Switzerland), Sinclair Pharma (U.K.), BIOPLUS CO.LTD. (South Korea), Bioxis Pharmaceuticals (France), DR. Korman (Israel), Prollenium Medical Technologies (Canada), and Teoxane (Switzerland) are some players on this company. These businesses of organizations who are leaders in the discipline offer a level gambling region for all their opposition as they guarantee increase and set necessities for the area.
In February 2023, ALLERGAN (AbbVie) introduced JUVEDERM VOLUX XC for the management of mild to severe jaw transformation in adults over 21 years of age.
Segmentation Table
Global Hyaluronic Acid Based Dermal Fillers Market Scope
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 8.1% From 2023-2030
Unit Value (USD billion)
Segmentation By Crosslinking Type, Application, End-user, and Region
By Crosslinking TypeMonophasic
Biphasic
ByApplication Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others
ByEnd-userSpecialty & Dermatology Clinics
Hospitals & Clinics
Others
By Region North America (By Crosslinking Type, By Application, By End-user, and By Country)
- U.S. (By Application)
- Canada (By Application)
Europe (By Crosslinking Type, By Application, By End-user, and By Country)
- U.K. (By Application)
- Germany (By Application)
- France (By Application)
- Italy (By Application)
- Spain (By Application)
- Scandinavia (By Application)
- Rest of Europe (By Application)
Asia Pacific (By Crosslinking Type, By Application, By End-user, and By Country)
- Japan (By Application)
- China (By Application)
- India (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
Latin America (By Crosslinking Type, By Application, By End-user, and By Country)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
Middle East & Africa (By Crosslinking Type, By Application, By End-user, and By Country)
- South Africa (By Application)
- GCC (By Application)
- Rest of Middle East & Africa (By Application)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.